Hyppää sisältöön
    • Suomeksi
    • På svenska
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • LUTPub
  • Tieteelliset julkaisut
  • Näytä aineisto
  •   Etusivu
  • LUTPub
  • Tieteelliset julkaisut
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Removal of pharmaceutically active compounds (PhACs) from real membrane bioreactor (MBR) effluents by photocatalytic degradation using composite Ag2O/P-25 photocatalyst

Gurung, Khum; Ncibi, Mohamed Chaker; Thangaraj, Senthil K.; Jänis, Janne; Seyedsalehi, Mahdi; Sillanpää, Mika (2019-01-03)

Katso/Avaa
gurung_et_al_removal_of_pharmaceutically_active_compounds_aam.pdf (2.182Mb)
Lataukset: 


Post-print / Final draft

Gurung, Khum
Ncibi, Mohamed Chaker
Thangaraj, Senthil K.
Jänis, Janne
Seyedsalehi, Mahdi
Sillanpää, Mika
03.01.2019

Separation and Purification Technology

215

317-328

Elsevier

School of Engineering Science

https://doi.org/10.1016/j.seppur.2018.12.069
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe201902256129

Tiivistelmä

Pharmaceutically active compounds (PhACs) are emerging pollutants causing serious challenges to wastewater treatment plants due to poor biodegradability. In this study, the enhanced removal of highly recalcitrant and commonly monitored PhACs, carbamazepine (CBZ) and diclofenac (DCF) by heterogeneous photocatalysis was investigated using 5% Ag2O/P-25 photocatalyst. The photocatalyst was characterized by scanning electron microscope (SEM-EDX), Brunauer-Emmett-Teller (BET), Fourier transfer infrared spectroscopy (FTIR) and UV–vis diffuse reflectance spectra (UV-DRS). The effects of catalyst dose, initial pollutants concentration, and mineralization during the photocatalytic degradation of PhACs were investigated. The matrix effect was assessed in deionized water (DW) and real membrane bioreactor effluent (RME). Optimal CBZ and DCF removals of 89.10% and 93.5%, respectively for 180 min of UV irradiation were achieved at catalyst dosage of 0.4 g L−1 in DW matrix. However, the optimal catalyst dosages for CBZ and DCF in RME matrix were increased by factor 2 and 1.5, respectively, to achieve the same degree of removal. Declining trends of removal rate were observed when initial concentrations of both the PhACs were increased under optimal catalyst dosages, and kinetics seem to fit the Langmuir-Hinshelwood model. Photo-induced holes and OH were the dominant oxidation species involved in the photocatalytic degradation of the PhACs. A plausible reusability of 5% Ag2O/P-25 photocatalyst was observed for both the PhACs. Moreover, various aromatic/aliphatic intermediates generated during the photodegradation CBZ were identified using fourier-transform ion cyclotron resonance (FT-ICR) mass spectrometry, and a possible multi-step degradation pathway was proposed. Overall, the removal of PhACs using 5% Ag2O/P-25 photocatalyst showed promising results in real wastewater.

Lähdeviite

K. Gurung, M. Chaker Ncibi, S.K. Thangaraj, J. Jänis, M. Seyedsalehi, M. Sillanpää, Removal of pharmaceutically active compounds (PhACs) from real membrane bioreactor (MBR) effluents by photocatalytic degradation using composite Ag2O /P-25 photocatalyst, Separation and Purification Technology (2018), doi: https://doi.org/10.1016/j.seppur.2018.12.069

Alkuperäinen verkko-osoite

https://www.sciencedirect.com/science/article/pii/S1383586618337158?via%3Dihub
Kokoelmat
  • Tieteelliset julkaisut [1560]
LUT-yliopisto
PL 20
53851 Lappeenranta
Ota yhteyttä | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetKoulutusohjelmaAvainsanatSyöttöajatYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
LUT-yliopisto
PL 20
53851 Lappeenranta
Ota yhteyttä | Tietosuoja | Saavutettavuusseloste